Comprehensive Glaucoma Determination Method Utilizing Glaucoma Diagnosis Chip And Deformed Proteomics Cluster Analysis

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20130275349A1
SERIAL NO

13976967

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Provided is a technique for determining a physiological attribute in a mammal, including the onset or progression of human glaucoma, with high accuracy. The results of the determination of genotype date and the results of the determination of cytokine date are consolidated by a consolidated determination unit (114); comparison is made for determining as to which is larger, the number of Case determination procedures or the number of control determination procedures (S330); and it is determined as Case (glaucoma) when the number of Case determination procedures is larger and it is determined as Control (normal person) when the number of Control determination procedures is larger.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
SANTEN PHARMACEUTICAL CO LTDOSAKA JAPAN OSAKA

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Fuwa, Masahiro Nara, JP 4 32
Ikeda, Yoko Kyoto, JP 22 214
Kinoshita, Shigeru Osaka, JP 95 409
Mori, Kazuhiko Kyoto, JP 97 896
Nakano, Masakazu Kanagawa, JP 19 150
Tashiro, Kei Kyoto, JP 106 828
Tokuda, Yuichi Kyoto, JP 2 35
Ueno, Morio Kyoto, JP 16 59
Yagi, Katsumi Osaka, JP 14 170
Yagi, Tomohito Kyoto, JP 5 35
Yoshii, Kengo Osaka, JP 8 31

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation